The CX3C-chemokine fractalkine (CX3CL1) is detectable in serum of patients affected by active pityriasis rosea [27]

Journal of the European Academy of Dermatology and Venereology

Volumn 20, Issue 10, 2006, Pages 1366-1367

  Gangemi, S ^a,d   Cannavo S P ^a   Guarneri, F ^a   Merendino, R A ^a   Sturniolo, G C ^b   Minciullo, P L ^a   Di Pasquale, G ^a   Valenzise, M ^b   Drago, F ^c   Rebora, A ^c  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CX3C CHEMOKINE; FRACTALKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD DONOR; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC CELL; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFORMED CONSENT; LETTER; MALE; PITYRIASIS ROSEA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; STATISTICAL SIGNIFICANCE; STUDENT T TEST; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ACUTE DISEASE; ADOLESCENT; ADULT; CHEMOKINES, CX3C; FEMALE; HUMANS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PITYRIASIS ROSEA;

EID: 33750304867     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2006.01721.x     Document Type: Letter

References (10)

1. Drago F, Ranieri E, Malaguti F et al. Human herpesvirus 7 in pityriasis rosea. Lancet 1997; 349: 1367.
2. Watanabe T, Kawamura T, Jacob SE et al. Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6. J Invest Dermatol 2002; 119: 793.
3. Broccolo F, Drago F, Careddu AM et al. Additional evidence that pityriasis rosea is associated with reactivation of HHV-6 and HHV-7. J Invest Dermatol 2005; 124: 1234-1240.
4. Bajetto A, Bonavia R, Barbero S, Schettini G. Characterization of chemokines and their receptors in the central nervous system: physiopathological implications. J Neurochem 2002; 82: 1311.
5. Bazan JF, Bacon KB, Hardiman G et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997; 385: 640.
6. Papadopoulos EJ, Sassetti C, Saeki H et al. Fractalkine, a CX3C chemokine, is expressed by dendritic cells and is up-regulated upon dendritic cell maturation. Eur J Immunol 1999; 29: 2551.
7. Imai T, Hieshima K, Haskell C et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997; 91: 521.
8. Raychaudhuri SP, Jiang WY, Farber EM. Cellular localization of fractalkine at sites of inflammation: Antigen-presenting cells in psoriasis express high levels of fractalkine. Br J Dermatol 2001; 144: 1105.
9. Echigo T, Hasegawa M, Shimada Y, Takehara K, Sato S. Expression of fractalkine and its receptor, CX3CR1, in atopic dermatitis: Possible contribution to skin inflammation. J Allergy Clin Immunol 2004; 113: 940.
10. Nakano K, Tadagaki K, Isegawa Y et al. Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol 2003; 77: 8108-8115.